Shin-Cheh Chen

9PUBLICATIONS

89CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsPredictive and prognostic markersClinical midwifery

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 06, 2026

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|May 26, 2026

Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

|Jan 08, 2026

DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.

Komal Jhaveri, Sherene Loi, Erika Hamilton

|Oct 28, 2025

Clinical Scenarios Using Thoracodorsal and Lateral Thoracic Vessels Versus Internal Mammary Vessels in Bipedicled Deep Inferior Epigastric Perforator Flap Breast Reconstruction: A Comparative Study.

Chia-Fang Chen, David Chon-Fok Cheong, Wen-Ling Kuo

|May 09, 2025

Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.

Xichun Hu, Qingyuan Zhang, Tao Sun

|Sep 23, 2022

Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Chi-Chang Yu, Yun-Chung Cheung, Shir-Hwa Ueng

Pageof 2

Frequent Collaborators

Chi-Chang Yu

Yen-Shen Lu

Wen-Ling Kuo

Yun-Chung Cheung

Wei-Pang Chung

Yeon Hee Park

Ling-Ming Tseng

Seock-Ah Im

Peter Schmid

Qingyuan Zhang

Frequent Collaborators

Chi-Chang Yu

Yen-Shen Lu

Wen-Ling Kuo

Yun-Chung Cheung